Common use of Specific Permitted Uses and Disclosures Clause in Contracts

Specific Permitted Uses and Disclosures. Except as otherwise specified in this Agreement, AACVPR may Use or Disclose PHI on behalf of, or in order to provide services to, Participant to the extent such Use or Disclosure is reasonably necessary to facilitate Participant’s participation in the Registry, provided that such Use or Disclosure of PHI would not violate the HIPAA Regulations if done by Participant. Without limiting the generality of the foregoing, Participant further agrees that AACVPR may Use and Disclose the PHI received for the following specific purposes: (a) To analyze, aggregate, produce and publish data on clinical patterns of diagnosis, treatment and outcomes of patients to assist with Health Care Operations; (b) To produce reports of aggregated, de-identified data and data not identifiable by contributing Participant that describe the diagnosis, treatment and outcomes of patients to assist with Health Care Operations; (c) To evaluate Participant performance, develop effective interventions to improve outcomes at the national and local level, and provide feedback in the form of an individual participant’s OPR Data benchmarked against regional and national OPR Data to assist with Health Care Operations; and (d) To create, Use and share Limited Data Sets with Registry participants and with other researchers for Research in the area of health care, subject to Subsections 7.4(f) and

Specific Permitted Uses and Disclosures. Except as otherwise specified in this Agreement, AACVPR may Use or Disclose PHI on behalf of, or in order to provide services to, Participant to the extent such Use or Disclosure is reasonably necessary to facilitate Participant’s participation in the Registry, provided that such Use or Disclosure of PHI would not violate the HIPAA Regulations if done by Participant. Without limiting the generality of the foregoing, Participant further agrees that AACVPR may Use and Disclose the PHI received for the following specific purposes: (a) To analyze, aggregate, produce and publish data on clinical patterns of diagnosis, treatment and outcomes of patients to assist with Health Care Operations; (b) To produce reports of aggregated, de-identified data and data not identifiable by contributing Participant that describe the diagnosis, treatment and outcomes of patients to assist with Health Care Operations; (c) To evaluate Participant performance, develop effective interventions to improve outcomes at the national and local level, and provide feedback in the form of an individual participant’s OPR OCR Data benchmarked against regional and national OPR OCR Data to assist with Health Care Operations; and (d) To create, Use and share Limited Data Sets with Registry participants and with other researchers for Research in the area of health care, subject to Subsections 7.4(f) and

Specific Permitted Uses and Disclosures. Except as otherwise specified in this Agreement, AACVPR may Use or Disclose PHI on behalf of, or in order to provide services to, Participant to the extent such Use or Disclosure is reasonably necessary to facilitate Participant’s participation in the Registry, provided that such Use or Disclosure of PHI would not violate the HIPAA Regulations if done by Participant. Without limiting the generality of the foregoing, Participant further agrees that AACVPR may Use and Disclose the PHI received for the following specific purposes: (a) To analyze, aggregate, produce and publish data on clinical patterns of diagnosis, treatment and outcomes of patients to assist with Health Care Operations; (b) To produce reports of aggregated, de-identified data and data not identifiable by contributing Participant that describe the diagnosis, treatment and outcomes of patients to assist with Health Care Operations; (c) To evaluate Participant performance, develop effective interventions to improve outcomes at the national and local level, and provide feedback in the form of an individual participant’s OPR OCR Data benchmarked against regional and national OPR OCR Data to assist with Health Care Operations; and (d) To create, Use and share Limited Data Sets with Registry participants and with other researchers for Research in the area of health care, subject to Subsections 7.4(f) andand 7.6 below.

Specific Permitted Uses and Disclosures. Except as otherwise specified in this Agreement, AACVPR may Use or Disclose PHI on behalf of, or in order to provide services to, Participant to the extent such Use or Disclosure is reasonably necessary to facilitate Participant’s participation in the Registry, provided that such Use or Disclosure of PHI would not violate the HIPAA Regulations if done by Participant. Without limiting the generality of the foregoing, Participant further agrees that AACVPR may Use and Disclose the PHI received for the following specific purposes: (a) To analyze, aggregate, produce and publish data on clinical patterns of diagnosis, treatment and outcomes of patients to assist with Health Care Operations; (b) To produce reports of aggregated, de-identified data and data not identifiable by contributing Participant that describe the diagnosis, treatment and outcomes of patients to assist with Health Care Operations; (c) To evaluate Participant performance, develop effective interventions to improve outcomes at the national and local level, and provide feedback in the form of an individual participant’s OPR Data benchmarked against regional and national OPR Data to assist with Health Care Operations; and (d) To create, Use and share Limited Data Sets with Registry participants and with other researchers for Research in the area of health care, subject to Subsections 7.4(f) andand 7.6 below.